Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
21.54
-0.84 (-3.75%)
Feb 21, 2025, 4:00 PM EST - Market closed
Cidara Therapeutics Employees
Cidara Therapeutics had 69 employees as of December 31, 2023. The number of employees decreased by 4 or -5.48% compared to the previous year.
Employees
69
Change (1Y)
-4
Growth (1Y)
-5.48%
Revenue / Employee
$647,145
Profits / Employee
-$1,749,754
Market Cap
235.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CDTX News
- 3 days ago - Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer - GlobeNewsWire
- 11 days ago - Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention - Seeking Alpha
- 22 days ago - Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 3 months ago - Cidara: Potential To Change Flu Prophylaxis Landscape With CD388 - Seeking Alpha
- 3 months ago - Cidara Therapeutics Announces $105 Million Private Placement - GlobeNewsWire
- 3 months ago - Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference - GlobeNewsWire
- 3 months ago - Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences - GlobeNewsWire